As of April 2024 Ligand Pharmaceuticals has a market cap of $1.24 Billion. This makes Ligand Pharmaceuticals the world's 4808th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.24 B | 0.34% |
2023 | $1.24 B | 10.35% |
2022 | $1.12 B | -56.28% |
2021 | $2.58 B | 61.4% |
2020 | $1.59 B | -8.85% |
2019 | $1.75 B | -37.74% |
2018 | $2.81 B | -2.49% |
2017 | $2.88 B | 36.08% |
2016 | $2.12 B | -1.81% |
2015 | $2.16 B | 107.65% |
2014 | $1.04 B | -3.26% |
2013 | $1.07 B | 143.96% |
2012 | $0.44 B | 88.98% |
2011 | $0.23 B | 34.2% |
2010 | $0.17 B | -31.26% |
2009 | $0.25 B | -2.69% |
2008 | $0.26 B | -42.87% |
2007 | $0.45 B | -58.2% |
2006 | $1.08 B | 33.71% |
2005 | $0.81 B | -4.09% |
2004 | $0.84 B | -21% |
2003 | $1.07 B | 180.23% |
2002 | $0.38 B | -64.33% |
2001 | $1.07 B |
On Apr 25th, 2024 the market cap of Ligand Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.16 B | 28,085.33% | ๐บ๐ธ USA |
Pfizer PFE | $143.82 B | 11,411.22% | ๐บ๐ธ USA |
Eli Lilly LLY | $697.39 B | 55,715.69% | ๐บ๐ธ USA |
Amgen AMGN | $144.81 B | 11,489.84% | ๐บ๐ธ USA |
Baxter BAX | $20.44 B | 1,535.91% | ๐บ๐ธ USA |
Merck MRK | $332.33 B | 26,498.11% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $90.90 B | 7,175.14% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.98 B | 6,622.00% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | $0.21 B | -83.08% | ๐บ๐ธ USA |